In vivo efficacy of sitafloxacin in a new murine model of non-typeable Haemophilus influenzae pneumonia by sterile intratracheal tube

International Journal of Antimicrobial Agents

Volumn 34, Issue 3, 2009, Pages 210-214

  Nakamura, Shigeki ^a   Yanagihara, Katsunori ^a   Araki, Nobuko ^a   Morinaga, Yoshitomo ^a   Izumikawa, Koichi ^a   Seki, Masafumi ^a   Kakeya, Hiroshi ^a   Yamamoto, Yoshihiro ^a   Kamihira, Shimeru ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Haemophilus influenzae; Non typeable; Sitafloxacin; Sterile intratracheal tube

Indexed keywords

CIPROFLOXACIN; SITAFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; BACTERIAL PNEUMONIA; BRONCHIOLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; DRUG RESPONSE; ENDOTRACHEAL TUBE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PNEUMONIA; HISTOPATHOLOGY; IN VIVO STUDY; INFLAMMATORY CELL; INSTRUMENT STERILIZATION; LUNG ALVEOLUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ANIMALS; ANTI-BACTERIAL AGENTS; BRONCHIOLES; CIPROFLOXACIN; DISEASE MODELS, ANIMAL; FLUOROQUINOLONES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; INTUBATION, INTRATRACHEAL; MALE; MICE; PNEUMONIA, BACTERIAL; PULMONARY ALVEOLI; TIME FACTORS; TRACHEA; TREATMENT OUTCOME;

EID: 67650716732     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2009.03.011     Document Type: Article

References (17)

1. Everett E.D., Rham Jr. A.E., Adaniya R., Stevens D.L., and McNitt T.R. Haemophilus influenzae pneumonia in adults. JAMA 238 (1977) 319-321
2. Maciver I., Silverman S.H., Brown M.R., and O'Reilly T. Rat model of chronic lung infections caused by non-typable Haemophilus influenzae. J Med Microbiol 35 (1991) 139-147
3. Miyazaki S., Nunoya T., Matsumoto T., Tateda K., and Yamaguchi K. New murine model of bronchopneumonia due to cell-bound Haemophilus influenzae. J Infect Dis 175 (1997) 205-209
4. Slater L.N. A rat model of prolonged pulmonary infection due to nontypable Haemophilus influenzae. Am Rev Respir Dis 142 (1990) 1429-1435
5. Smith G.M., and Abbott K.H. Development of experimental respiratory infections in neutropenic rats with either penicillin-resistant Streptococcus pneumoniae or β-lactamase-producing Haemophilus influenzae. Antimicrob Agents Chemother 38 (1994) 608-610
6. Yanagihara K., Tomono K., Sawai T., Hirakata Y., Kadota J., Koga H., et al. Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 155 (1997) 337-342
7. Kaneko Y., Yanagihara K., Seki M., Kuroki M., Miyazaki Y., Hirakata Y., et al. Clarithromycin inhibits overproduction of muc5ac core protein in murine model of diffuse panbronchiolitis. Am J Physiol Lung Cell Mol Physiol 285 (2003) L847-L853
8. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Tenth informational supplement. M100-S10. Wayne, PA: NCCLS; 2000.
9. Fukuda Y., Yanagihara K., Ohno H., Higashiyama Y., Miyazaki Y., Tsukamoto K., et al. In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model. Antimicrob Agents Chemother 50 (2006) 121-125
10. Murphy T.F. Haemophilus infections. In: Braunwarld F., Fauci A.S., Kaspar D.L., Hauser S.L., Longo D.L., and Jameson J.L. (Eds). Harrisons principles of internal medicine. 15th ed. (2001), McGraw Hill, New York, NY 939-942
11. Sarangi J., Cartwright K., Stuart J., Brookes S., Morris R., Slack M., et al. Invasive Haemophilus influenzae disease in adults. Epidemiol Infect 124 (2000) 441-447
12. Wallace Jr. R.J., Musher D.M., and Martin R.R. Hemophilus influenzae pneumonia in adults. Am J Med 64 (1978) 87-93
13. Baker A.F. Bronchiectasis. N Engl J Med 346 (2002) 1383-1393
14. Murphy T.F. Haemophilus influenzae in chronic bronchitis. Semin Respir Infect 15 (2000) 41-51
15. Scaglione F., Scamazzo F., Arcidiacono M.M., Cogo R., Monzani G.P., and Fraschini F. Comparative activities of pefloxacin and ciprofloxacin in the treatment of chronic respiratory tract infections. J Chemother 2 (1995) 140-145
16. Milatovic D., Schmitz F.J., Brisse S., Verhoef J., and Fluit A.C. In vitro activities of sitafloxacin (DU-6859a) and six other fluoroquinolones against 8 796 clinical bacterial isolates. Antimicrob Agents Chemother 44 (2000) 1102-1107
17. Miyashita N., Niki Y., and Matsushima T. In vitro and in vivo activities of sitafloxacin against Chlamydia spp. Antimicrob Agents Chemother 45 (2001) 3270-3272